Evaluation of the relation of BRAF inhibitor resistance and HIF1 regulation in malignant melanoma cell lines

被引：0
|
作者：
Baskin, Yasemin [1 ]
机构：
[1] Dokuz Eylul Univ, Inst Oncol, Alsancak, Turkey
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
5518
引用
收藏
页码：AB133 / AB133
页数：1
相关论文
共 50 条
  • [21] A secondary role for hypoxia and HIF1 in the regulation of (IFNgamma-induced) PD-L1 expression in melanoma
    Van Duijn, Anneloes
    Willemsen, Karin J.
    Van Uden, Nathalie O. P.
    Hoyng, Lieke
    Erades, Sterre
    Koster, Jan
    Luiten, Rosalie M.
    Bakker, Walbert J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 243 - 243
  • [22] Expression and hypoxic regulation of hif1α and hif2α during early blood and endothelial cell differentiation in chick
    Ota, Kanako
    Nagai, Hiroki
    Sheng, Guojun
    GENE EXPRESSION PATTERNS, 2007, 7 (07) : 761 - 766
  • [23] Identification of NRAS isoform 2 overexpression as a novel mechanism facilitating BRAF inhibitor resistance in malignant melanoma (MM)
    Duggan, Megan
    Stiff, Andrew
    Salavaggione, Gonzalo Olaverria
    Bainazar, Maryam
    Latchana, Nicholas
    Markowitz, Joseph
    de la Chapelle, Albert
    Eisfeld, Ann-Kathrin
    Carson, William
    CANCER RESEARCH, 2016, 76
  • [24] PDGFRα up-regulation mediated by Sonic Hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation
    Sabbatino, Francesco
    Wang, Yangyang
    Wang, Xinhui
    Flaherty, Keith T.
    Yu, Ling
    Pepin, David
    Scognamiglio, Giosue
    Pepe, Stefano
    Kirkwood, John M.
    Cooper, Zachary A.
    Frederick, Dennie T.
    Wargo, Jennifer A.
    Ferrone, Soldano
    Ferrone, Cristina R.
    ONCOTARGET, 2014, 5 (07) : 1926 - 1941
  • [25] PDGFRα up-regulation mediated by Sonic Hedgehog Pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation
    Sabbatino, Francesco
    Wang, Yangyang
    Wang, Xinhui
    Flaherty, Keith T.
    Pepin, David
    Scognamiglio, Giosue
    Yu, Ling
    Cooper, Zachary A.
    Pepe, Stefano
    Kirkwood, John M.
    Frederick, Dennie T.
    Wargo, Jennifer A.
    Ferrone, Soldano
    Ferrone, Cristina R.
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells
    Misek, Sean A.
    Newbury, Patrick A.
    Chekalin, Evgenii
    Paithankar, Shreya
    Doseff, Andrea, I
    Chen, Bin
    Gallo, Kathleen A.
    Neubig, Richard R.
    MOLECULAR PHARMACOLOGY, 2022, 101 (01) : 1 - 12
  • [27] SOX4 Mediates BRAF Inhibitor Resistance in Melanoma through Regulation of IGF-1R Signaling: In Vitro Study
    Liu Xiao
    Mi Jun
    Qin Hai-Hong
    He Shan
    Li Zheng
    Chai Jing-Xiu
    Li Ming
    Xu Jin-Hua
    Wu Jin-Feng
    国际皮肤性病学杂志（英文）, 2020, 03 (03) : 156 - 165
  • [28] Proteasomal down- regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma
    Romano, David
    Garcia-Gutierrez, Lucia
    Aboud, Nourhan
    Duffy, David J.
    Flaherty, Keith T.
    Frederick, Dennie T.
    Kolch, Walter
    Matallanas, David
    LIFE SCIENCE ALLIANCE, 2022, 5 (10)
  • [29] Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
    Alex J Eustace
    John Crown
    Martin Clynes
    Norma O'Donovan
    Journal of Translational Medicine, 6
  • [30] Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
    Eustace, Alex J.
    Crown, John
    Clynes, Martin
    O'Donovan, Norma
    JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
12345